The development of a new catalyst, which has not been explored before, not only provides an alternative to the existing organocatalysts but also leads to a distinct chemical reactivity. Here, an organotellurium catalyst consisting of a chiral quinine auxiliary displays remarkable activity for the enantioselective delivery of reactive arylselenols as a Michael donor in common solvents such as dichloromethane and acetonitrile. The developed chiral organotellurium-catalyzed arylselenol addition to alkenes shows a broad substrate scope as electron-rich and deficient arylselenols and diversely substituted enones are amenable to the reaction conditions. Control experiments, 77Se, and 125Te NMR, suggest that non-bonded Te...Se interaction between catalyst and arylselenol seems responsible for accelerated and highly enantioselective delivery of arylselenol to enone. The practically synthesized chiral organoselenides have also been readily post-derivatized by taking advantage of the leaving group ability and recyclability of arylselenium.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: